| SHIONOGI + CO. LTD |
| Japan |
| Gesundheit |
| JP3347200002 / 855648 |
| SH0 (Frankfurt) |
| FRA:SH0, ETR:SH0, SH0:GR |
| Nikkei225 |
| http://www.shionogi.co.jp.. |
|
Shionogi & Co., Ltd. is a prominent pharmaceutical company originating from Japan, specializing in research, development, and commercialization of medicines. Its central focus is on addressing infectious diseases, with a strong dedication to innovati..
>Volltext.. |
| 14432.15 Mio. EUR |
| 16513.48 Mio. EUR |
| 3027.06 Mio. EUR |
| 1116.3 Mio. EUR |
| 1416.24 Mio. EUR |
| 1.66 EUR |
| 3677 Mio. EUR |
| 1606.7 Mio. EUR |
| 1158.99 Mio. EUR |
| 0.37 |
| 16.87% |
| 34.44% |
| 0.37 EUR |
| 2.4% |
| 2.71% |
| 30.03.26 - 0.18012688€ 29.09.25 - 0.1880208€ >weitere anzeigen... |
| - |
| SHIONOGI |
| 23.09.26 |
|
||||
|